Showing results (361-370 of 6,286) with videos related to

Sort By:
Pageof 629
Diabetes, Obesity & Metabolism|June 20, 2001
Hormone replacement therapy for postmenopausal women with diabetesS L Palin, S Kumar, D W Sturdee, et al.
Diabetes, Obesity & Metabolism|June 20, 2001
Oral gavage of oleoyl-oestrone has a stronger effect on body weight in male Zucker obese rats than in femaleM M Grasa, M Esteve, R M Masanés, et al.
Diabetes, Obesity & Metabolism|June 6, 2002
Effect of misoprostol (PGE1) on glucose metabolism in type-2-diabetic and control subjectsN A Lee, M Matsuda, P Bressler, et al.
Diabetes, Obesity & Metabolism|June 6, 2002
Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetesA J Garber, J Larsen, S H Schneider, et al.
Diabetes, Obesity & Metabolism|April 12, 2003
Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetesT A Jones, M Sautter, L F Van Gaal, et al.
Diabetes, Obesity & Metabolism|April 19, 2003
Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance) in type 2 diabetesA Garber, M Marre, L Blonde, et al.
Diabetes, Obesity & Metabolism|April 12, 2003
Decreasing levels of tumour necrosis factor alpha and interleukin 6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk factorsL Samuelsson, A Gottsäter, F Lindgärde
Diabetes, Obesity & Metabolism|August 28, 2003
Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in human abdominal subcutaneous adipocytesA L Harte, P G McTernan, C L McTernan, et al.
Diabetes, Obesity & Metabolism|August 28, 2003
Effects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetesJ B Howes, D Tran, D Brillante, et al.
Diabetes, Obesity & Metabolism|August 28, 2003
Sibutramine enhances insulin sensitivity ameliorating metabolic parameters in a double-blind, randomized, placebo-controlled trialM A Tambascia, B Geloneze, E M Repetto, et al.
Pageof 629